STEM CELLS AND DEVELOPMENT-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2131287, encodeId=4228213128e14, content=偏重的研究方向：干细胞 经验分享：我想请问参考文献统一格式是endnote哪种格式，求告知，拜托。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Wed May 10 01:57:58 CST 2023, time=2023-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107376, encodeId=3405210e376b5, content=请问这个期刊可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Dec 25 00:15:21 CST 2022, time=2022-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586208, encodeId=902d586208ca, content=请问该杂志允许有共同第一作者嘛？jianglin9112 2020-01-13 发表:: 可以用信用卡jianglin9112 2020-01-13 00:00:00 发表: 可以用信用卡, beContent=jianglin9112 2020-01-13 发表:: 可以用信用卡, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab905306038, createdName=148789b3m17(暂无昵称), createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515864, encodeId=702d5158645d, content=atlaswang072650投了多久有消息的？为嘛我投了一篇当时就under view，到现在一个多月的还是under view，一点变化没有呢？太悲催了，另一篇投了个欧洲杂志，都快四个月了也还没消息，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/78bcaa77d72d4dc7ac25ab16c7d8ddec/d5dca58b57b849a79ee3182ba4376d18.jpg, createdBy=c15d1629831, createdName=bingliangai, createdTime=Sun Oct 11 18:00:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137199, encodeId=e147213e199e6, content=投稿命中率:25.0 偏重的研究方向：干细胞 经验分享：这个直接拒稿了，投稿链接不好弄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/4F41B2F8F8D000E5AB77C572AE53CAE6/100, createdBy=9ed52073694, createdName=ms3590975155672967, createdTime=Wed May 17 21:09:15 CST 2023, time=2023-05-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125934, encodeId=e639212593475, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：干细胞 经验分享：想问一下，大家修回去之后，大概多久有回复呀，大修返回去已经3个星期了，着急毕业呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:32:33 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125936, encodeId=2e902125936ed, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：请问一下大修返回去之后，一般是多久有回复呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:33:52 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1240494, encodeId=115a1240494e0, content=请问各位投稿成功的前辈，投稿必须要指定审稿人吗？对期刊审稿人并不了解，不知道填写谁该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ca6548418, createdName=ms5000000331764313, createdTime=Tue Aug 23 11:22:28 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214637, encodeId=a545121463efa, content=请问各位老师，杂志对综述友好吗？求解答～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037d5635603, createdName=ms4000001299708160, createdTime=Tue Apr 26 15:51:07 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208975, encodeId=817d12089e54a, content=请问对单位是医院会不会被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fa13814629, createdName=136dac36m33暂无昵称, createdTime=Wed Apr 06 14:24:44 CST 2022, time=2022-04-06, status=1, ipAttribution=)]

2023-05-10 ms1000000465565248 来自江苏省

偏重的研究方向：干细胞
经验分享：我想请问参考文献统一格式是endnote哪种格式，求告知，拜托。

35 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131287, encodeId=4228213128e14, content=偏重的研究方向：干细胞 经验分享：我想请问参考文献统一格式是endnote哪种格式，求告知，拜托。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Wed May 10 01:57:58 CST 2023, time=2023-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107376, encodeId=3405210e376b5, content=请问这个期刊可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Dec 25 00:15:21 CST 2022, time=2022-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586208, encodeId=902d586208ca, content=请问该杂志允许有共同第一作者嘛？jianglin9112 2020-01-13 发表:: 可以用信用卡jianglin9112 2020-01-13 00:00:00 发表: 可以用信用卡, beContent=jianglin9112 2020-01-13 发表:: 可以用信用卡, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab905306038, createdName=148789b3m17(暂无昵称), createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515864, encodeId=702d5158645d, content=atlaswang072650投了多久有消息的？为嘛我投了一篇当时就under view，到现在一个多月的还是under view，一点变化没有呢？太悲催了，另一篇投了个欧洲杂志，都快四个月了也还没消息，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/78bcaa77d72d4dc7ac25ab16c7d8ddec/d5dca58b57b849a79ee3182ba4376d18.jpg, createdBy=c15d1629831, createdName=bingliangai, createdTime=Sun Oct 11 18:00:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137199, encodeId=e147213e199e6, content=投稿命中率:25.0 偏重的研究方向：干细胞 经验分享：这个直接拒稿了，投稿链接不好弄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/4F41B2F8F8D000E5AB77C572AE53CAE6/100, createdBy=9ed52073694, createdName=ms3590975155672967, createdTime=Wed May 17 21:09:15 CST 2023, time=2023-05-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125934, encodeId=e639212593475, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：干细胞 经验分享：想问一下，大家修回去之后，大概多久有回复呀，大修返回去已经3个星期了，着急毕业呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:32:33 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125936, encodeId=2e902125936ed, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：请问一下大修返回去之后，一般是多久有回复呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:33:52 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1240494, encodeId=115a1240494e0, content=请问各位投稿成功的前辈，投稿必须要指定审稿人吗？对期刊审稿人并不了解，不知道填写谁该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ca6548418, createdName=ms5000000331764313, createdTime=Tue Aug 23 11:22:28 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214637, encodeId=a545121463efa, content=请问各位老师，杂志对综述友好吗？求解答～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037d5635603, createdName=ms4000001299708160, createdTime=Tue Apr 26 15:51:07 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208975, encodeId=817d12089e54a, content=请问对单位是医院会不会被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fa13814629, createdName=136dac36m33暂无昵称, createdTime=Wed Apr 06 14:24:44 CST 2022, time=2022-04-06, status=1, ipAttribution=)]

2022-12-25 ms9000001570698815 来自湖北省

请问这个期刊可以选择非OA吗？

79 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131287, encodeId=4228213128e14, content=偏重的研究方向：干细胞 经验分享：我想请问参考文献统一格式是endnote哪种格式，求告知，拜托。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Wed May 10 01:57:58 CST 2023, time=2023-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107376, encodeId=3405210e376b5, content=请问这个期刊可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Dec 25 00:15:21 CST 2022, time=2022-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586208, encodeId=902d586208ca, content=请问该杂志允许有共同第一作者嘛？jianglin9112 2020-01-13 发表:: 可以用信用卡jianglin9112 2020-01-13 00:00:00 发表: 可以用信用卡, beContent=jianglin9112 2020-01-13 发表:: 可以用信用卡, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab905306038, createdName=148789b3m17(暂无昵称), createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515864, encodeId=702d5158645d, content=atlaswang072650投了多久有消息的？为嘛我投了一篇当时就under view，到现在一个多月的还是under view，一点变化没有呢？太悲催了，另一篇投了个欧洲杂志，都快四个月了也还没消息，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/78bcaa77d72d4dc7ac25ab16c7d8ddec/d5dca58b57b849a79ee3182ba4376d18.jpg, createdBy=c15d1629831, createdName=bingliangai, createdTime=Sun Oct 11 18:00:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137199, encodeId=e147213e199e6, content=投稿命中率:25.0 偏重的研究方向：干细胞 经验分享：这个直接拒稿了，投稿链接不好弄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/4F41B2F8F8D000E5AB77C572AE53CAE6/100, createdBy=9ed52073694, createdName=ms3590975155672967, createdTime=Wed May 17 21:09:15 CST 2023, time=2023-05-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125934, encodeId=e639212593475, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：干细胞 经验分享：想问一下，大家修回去之后，大概多久有回复呀，大修返回去已经3个星期了，着急毕业呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:32:33 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125936, encodeId=2e902125936ed, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：请问一下大修返回去之后，一般是多久有回复呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:33:52 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1240494, encodeId=115a1240494e0, content=请问各位投稿成功的前辈，投稿必须要指定审稿人吗？对期刊审稿人并不了解，不知道填写谁该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ca6548418, createdName=ms5000000331764313, createdTime=Tue Aug 23 11:22:28 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214637, encodeId=a545121463efa, content=请问各位老师，杂志对综述友好吗？求解答～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037d5635603, createdName=ms4000001299708160, createdTime=Tue Apr 26 15:51:07 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208975, encodeId=817d12089e54a, content=请问对单位是医院会不会被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fa13814629, createdName=136dac36m33暂无昵称, createdTime=Wed Apr 06 14:24:44 CST 2022, time=2022-04-06, status=1, ipAttribution=)]

2020-03-09 148789b3m17(暂无昵称)

请问该杂志允许有共同第一作者嘛？jianglin9112 2020-01-13 发表::
可以用信用卡jianglin9112 2020-01-13 00:00:00 发表:
可以用信用卡

jianglin9112 2020-01-13 发表:: 可以用信用卡

169 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131287, encodeId=4228213128e14, content=偏重的研究方向：干细胞 经验分享：我想请问参考文献统一格式是endnote哪种格式，求告知，拜托。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Wed May 10 01:57:58 CST 2023, time=2023-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107376, encodeId=3405210e376b5, content=请问这个期刊可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Dec 25 00:15:21 CST 2022, time=2022-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586208, encodeId=902d586208ca, content=请问该杂志允许有共同第一作者嘛？jianglin9112 2020-01-13 发表:: 可以用信用卡jianglin9112 2020-01-13 00:00:00 发表: 可以用信用卡, beContent=jianglin9112 2020-01-13 发表:: 可以用信用卡, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab905306038, createdName=148789b3m17(暂无昵称), createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515864, encodeId=702d5158645d, content=atlaswang072650投了多久有消息的？为嘛我投了一篇当时就under view，到现在一个多月的还是under view，一点变化没有呢？太悲催了，另一篇投了个欧洲杂志，都快四个月了也还没消息，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/78bcaa77d72d4dc7ac25ab16c7d8ddec/d5dca58b57b849a79ee3182ba4376d18.jpg, createdBy=c15d1629831, createdName=bingliangai, createdTime=Sun Oct 11 18:00:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137199, encodeId=e147213e199e6, content=投稿命中率:25.0 偏重的研究方向：干细胞 经验分享：这个直接拒稿了，投稿链接不好弄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/4F41B2F8F8D000E5AB77C572AE53CAE6/100, createdBy=9ed52073694, createdName=ms3590975155672967, createdTime=Wed May 17 21:09:15 CST 2023, time=2023-05-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125934, encodeId=e639212593475, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：干细胞 经验分享：想问一下，大家修回去之后，大概多久有回复呀，大修返回去已经3个星期了，着急毕业呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:32:33 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125936, encodeId=2e902125936ed, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：请问一下大修返回去之后，一般是多久有回复呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:33:52 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1240494, encodeId=115a1240494e0, content=请问各位投稿成功的前辈，投稿必须要指定审稿人吗？对期刊审稿人并不了解，不知道填写谁该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ca6548418, createdName=ms5000000331764313, createdTime=Tue Aug 23 11:22:28 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214637, encodeId=a545121463efa, content=请问各位老师，杂志对综述友好吗？求解答～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037d5635603, createdName=ms4000001299708160, createdTime=Tue Apr 26 15:51:07 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208975, encodeId=817d12089e54a, content=请问对单位是医院会不会被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fa13814629, createdName=136dac36m33暂无昵称, createdTime=Wed Apr 06 14:24:44 CST 2022, time=2022-04-06, status=1, ipAttribution=)]

2015-10-11 bingliangai

atlaswang072650投了多久有消息的？为嘛我投了一篇当时就under view，到现在一个多月的还是under view，一点变化没有呢？太悲催了，另一篇投了个欧洲杂志，都快四个月了也还没消息，唉

560 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131287, encodeId=4228213128e14, content=偏重的研究方向：干细胞 经验分享：我想请问参考文献统一格式是endnote哪种格式，求告知，拜托。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Wed May 10 01:57:58 CST 2023, time=2023-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107376, encodeId=3405210e376b5, content=请问这个期刊可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Dec 25 00:15:21 CST 2022, time=2022-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586208, encodeId=902d586208ca, content=请问该杂志允许有共同第一作者嘛？jianglin9112 2020-01-13 发表:: 可以用信用卡jianglin9112 2020-01-13 00:00:00 发表: 可以用信用卡, beContent=jianglin9112 2020-01-13 发表:: 可以用信用卡, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab905306038, createdName=148789b3m17(暂无昵称), createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515864, encodeId=702d5158645d, content=atlaswang072650投了多久有消息的？为嘛我投了一篇当时就under view，到现在一个多月的还是under view，一点变化没有呢？太悲催了，另一篇投了个欧洲杂志，都快四个月了也还没消息，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/78bcaa77d72d4dc7ac25ab16c7d8ddec/d5dca58b57b849a79ee3182ba4376d18.jpg, createdBy=c15d1629831, createdName=bingliangai, createdTime=Sun Oct 11 18:00:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137199, encodeId=e147213e199e6, content=投稿命中率:25.0 偏重的研究方向：干细胞 经验分享：这个直接拒稿了，投稿链接不好弄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/4F41B2F8F8D000E5AB77C572AE53CAE6/100, createdBy=9ed52073694, createdName=ms3590975155672967, createdTime=Wed May 17 21:09:15 CST 2023, time=2023-05-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125934, encodeId=e639212593475, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：干细胞 经验分享：想问一下，大家修回去之后，大概多久有回复呀，大修返回去已经3个星期了，着急毕业呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:32:33 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125936, encodeId=2e902125936ed, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：请问一下大修返回去之后，一般是多久有回复呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:33:52 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1240494, encodeId=115a1240494e0, content=请问各位投稿成功的前辈，投稿必须要指定审稿人吗？对期刊审稿人并不了解，不知道填写谁该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ca6548418, createdName=ms5000000331764313, createdTime=Tue Aug 23 11:22:28 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214637, encodeId=a545121463efa, content=请问各位老师，杂志对综述友好吗？求解答～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037d5635603, createdName=ms4000001299708160, createdTime=Tue Apr 26 15:51:07 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208975, encodeId=817d12089e54a, content=请问对单位是医院会不会被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fa13814629, createdName=136dac36m33暂无昵称, createdTime=Wed Apr 06 14:24:44 CST 2022, time=2022-04-06, status=1, ipAttribution=)]

2023-05-17 ms3590975155672967 来自湖南省

投稿命中率:25.0
偏重的研究方向：干细胞
经验分享：这个直接拒稿了，投稿链接不好弄

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2131287, encodeId=4228213128e14, content=偏重的研究方向：干细胞 经验分享：我想请问参考文献统一格式是endnote哪种格式，求告知，拜托。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Wed May 10 01:57:58 CST 2023, time=2023-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107376, encodeId=3405210e376b5, content=请问这个期刊可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Dec 25 00:15:21 CST 2022, time=2022-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586208, encodeId=902d586208ca, content=请问该杂志允许有共同第一作者嘛？jianglin9112 2020-01-13 发表:: 可以用信用卡jianglin9112 2020-01-13 00:00:00 发表: 可以用信用卡, beContent=jianglin9112 2020-01-13 发表:: 可以用信用卡, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab905306038, createdName=148789b3m17(暂无昵称), createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515864, encodeId=702d5158645d, content=atlaswang072650投了多久有消息的？为嘛我投了一篇当时就under view，到现在一个多月的还是under view，一点变化没有呢？太悲催了，另一篇投了个欧洲杂志，都快四个月了也还没消息，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/78bcaa77d72d4dc7ac25ab16c7d8ddec/d5dca58b57b849a79ee3182ba4376d18.jpg, createdBy=c15d1629831, createdName=bingliangai, createdTime=Sun Oct 11 18:00:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137199, encodeId=e147213e199e6, content=投稿命中率:25.0 偏重的研究方向：干细胞 经验分享：这个直接拒稿了，投稿链接不好弄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/4F41B2F8F8D000E5AB77C572AE53CAE6/100, createdBy=9ed52073694, createdName=ms3590975155672967, createdTime=Wed May 17 21:09:15 CST 2023, time=2023-05-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125934, encodeId=e639212593475, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：干细胞 经验分享：想问一下，大家修回去之后，大概多久有回复呀，大修返回去已经3个星期了，着急毕业呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:32:33 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125936, encodeId=2e902125936ed, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：请问一下大修返回去之后，一般是多久有回复呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:33:52 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1240494, encodeId=115a1240494e0, content=请问各位投稿成功的前辈，投稿必须要指定审稿人吗？对期刊审稿人并不了解，不知道填写谁该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ca6548418, createdName=ms5000000331764313, createdTime=Tue Aug 23 11:22:28 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214637, encodeId=a545121463efa, content=请问各位老师，杂志对综述友好吗？求解答～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037d5635603, createdName=ms4000001299708160, createdTime=Tue Apr 26 15:51:07 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208975, encodeId=817d12089e54a, content=请问对单位是医院会不会被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fa13814629, createdName=136dac36m33暂无昵称, createdTime=Wed Apr 06 14:24:44 CST 2022, time=2022-04-06, status=1, ipAttribution=)]

2023-04-14 ms2000000928550846 来自四川省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：干细胞
经验分享：想问一下，大家修回去之后，大概多久有回复呀，大修返回去已经3个星期了，着急毕业呀

40 0

[GetPortalCommentsPageByObjectIdResponse(id=2131287, encodeId=4228213128e14, content=偏重的研究方向：干细胞 经验分享：我想请问参考文献统一格式是endnote哪种格式，求告知，拜托。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Wed May 10 01:57:58 CST 2023, time=2023-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107376, encodeId=3405210e376b5, content=请问这个期刊可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Dec 25 00:15:21 CST 2022, time=2022-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586208, encodeId=902d586208ca, content=请问该杂志允许有共同第一作者嘛？jianglin9112 2020-01-13 发表:: 可以用信用卡jianglin9112 2020-01-13 00:00:00 发表: 可以用信用卡, beContent=jianglin9112 2020-01-13 发表:: 可以用信用卡, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab905306038, createdName=148789b3m17(暂无昵称), createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515864, encodeId=702d5158645d, content=atlaswang072650投了多久有消息的？为嘛我投了一篇当时就under view，到现在一个多月的还是under view，一点变化没有呢？太悲催了，另一篇投了个欧洲杂志，都快四个月了也还没消息，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/78bcaa77d72d4dc7ac25ab16c7d8ddec/d5dca58b57b849a79ee3182ba4376d18.jpg, createdBy=c15d1629831, createdName=bingliangai, createdTime=Sun Oct 11 18:00:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137199, encodeId=e147213e199e6, content=投稿命中率:25.0 偏重的研究方向：干细胞 经验分享：这个直接拒稿了，投稿链接不好弄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/4F41B2F8F8D000E5AB77C572AE53CAE6/100, createdBy=9ed52073694, createdName=ms3590975155672967, createdTime=Wed May 17 21:09:15 CST 2023, time=2023-05-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125934, encodeId=e639212593475, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：干细胞 经验分享：想问一下，大家修回去之后，大概多久有回复呀，大修返回去已经3个星期了，着急毕业呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:32:33 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125936, encodeId=2e902125936ed, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：请问一下大修返回去之后，一般是多久有回复呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:33:52 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1240494, encodeId=115a1240494e0, content=请问各位投稿成功的前辈，投稿必须要指定审稿人吗？对期刊审稿人并不了解，不知道填写谁该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ca6548418, createdName=ms5000000331764313, createdTime=Tue Aug 23 11:22:28 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214637, encodeId=a545121463efa, content=请问各位老师，杂志对综述友好吗？求解答～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037d5635603, createdName=ms4000001299708160, createdTime=Tue Apr 26 15:51:07 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208975, encodeId=817d12089e54a, content=请问对单位是医院会不会被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fa13814629, createdName=136dac36m33暂无昵称, createdTime=Wed Apr 06 14:24:44 CST 2022, time=2022-04-06, status=1, ipAttribution=)]

2023-04-14 ms2000000928550846 来自四川省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：干细胞
经验分享：请问一下大修返回去之后，一般是多久有回复呢？

39 0

[GetPortalCommentsPageByObjectIdResponse(id=2131287, encodeId=4228213128e14, content=偏重的研究方向：干细胞 经验分享：我想请问参考文献统一格式是endnote哪种格式，求告知，拜托。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Wed May 10 01:57:58 CST 2023, time=2023-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107376, encodeId=3405210e376b5, content=请问这个期刊可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Dec 25 00:15:21 CST 2022, time=2022-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586208, encodeId=902d586208ca, content=请问该杂志允许有共同第一作者嘛？jianglin9112 2020-01-13 发表:: 可以用信用卡jianglin9112 2020-01-13 00:00:00 发表: 可以用信用卡, beContent=jianglin9112 2020-01-13 发表:: 可以用信用卡, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab905306038, createdName=148789b3m17(暂无昵称), createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515864, encodeId=702d5158645d, content=atlaswang072650投了多久有消息的？为嘛我投了一篇当时就under view，到现在一个多月的还是under view，一点变化没有呢？太悲催了，另一篇投了个欧洲杂志，都快四个月了也还没消息，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/78bcaa77d72d4dc7ac25ab16c7d8ddec/d5dca58b57b849a79ee3182ba4376d18.jpg, createdBy=c15d1629831, createdName=bingliangai, createdTime=Sun Oct 11 18:00:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137199, encodeId=e147213e199e6, content=投稿命中率:25.0 偏重的研究方向：干细胞 经验分享：这个直接拒稿了，投稿链接不好弄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/4F41B2F8F8D000E5AB77C572AE53CAE6/100, createdBy=9ed52073694, createdName=ms3590975155672967, createdTime=Wed May 17 21:09:15 CST 2023, time=2023-05-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125934, encodeId=e639212593475, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：干细胞 经验分享：想问一下，大家修回去之后，大概多久有回复呀，大修返回去已经3个星期了，着急毕业呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:32:33 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125936, encodeId=2e902125936ed, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：请问一下大修返回去之后，一般是多久有回复呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:33:52 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1240494, encodeId=115a1240494e0, content=请问各位投稿成功的前辈，投稿必须要指定审稿人吗？对期刊审稿人并不了解，不知道填写谁该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ca6548418, createdName=ms5000000331764313, createdTime=Tue Aug 23 11:22:28 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214637, encodeId=a545121463efa, content=请问各位老师，杂志对综述友好吗？求解答～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037d5635603, createdName=ms4000001299708160, createdTime=Tue Apr 26 15:51:07 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208975, encodeId=817d12089e54a, content=请问对单位是医院会不会被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fa13814629, createdName=136dac36m33暂无昵称, createdTime=Wed Apr 06 14:24:44 CST 2022, time=2022-04-06, status=1, ipAttribution=)]

2022-08-23 ms5000000331764313

请问各位投稿成功的前辈，投稿必须要指定审稿人吗？对期刊审稿人并不了解，不知道填写谁该怎么办呢？

44 0

[GetPortalCommentsPageByObjectIdResponse(id=2131287, encodeId=4228213128e14, content=偏重的研究方向：干细胞 经验分享：我想请问参考文献统一格式是endnote哪种格式，求告知，拜托。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Wed May 10 01:57:58 CST 2023, time=2023-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107376, encodeId=3405210e376b5, content=请问这个期刊可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Dec 25 00:15:21 CST 2022, time=2022-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586208, encodeId=902d586208ca, content=请问该杂志允许有共同第一作者嘛？jianglin9112 2020-01-13 发表:: 可以用信用卡jianglin9112 2020-01-13 00:00:00 发表: 可以用信用卡, beContent=jianglin9112 2020-01-13 发表:: 可以用信用卡, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab905306038, createdName=148789b3m17(暂无昵称), createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515864, encodeId=702d5158645d, content=atlaswang072650投了多久有消息的？为嘛我投了一篇当时就under view，到现在一个多月的还是under view，一点变化没有呢？太悲催了，另一篇投了个欧洲杂志，都快四个月了也还没消息，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/78bcaa77d72d4dc7ac25ab16c7d8ddec/d5dca58b57b849a79ee3182ba4376d18.jpg, createdBy=c15d1629831, createdName=bingliangai, createdTime=Sun Oct 11 18:00:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137199, encodeId=e147213e199e6, content=投稿命中率:25.0 偏重的研究方向：干细胞 经验分享：这个直接拒稿了，投稿链接不好弄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/4F41B2F8F8D000E5AB77C572AE53CAE6/100, createdBy=9ed52073694, createdName=ms3590975155672967, createdTime=Wed May 17 21:09:15 CST 2023, time=2023-05-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125934, encodeId=e639212593475, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：干细胞 经验分享：想问一下，大家修回去之后，大概多久有回复呀，大修返回去已经3个星期了，着急毕业呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:32:33 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125936, encodeId=2e902125936ed, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：请问一下大修返回去之后，一般是多久有回复呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:33:52 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1240494, encodeId=115a1240494e0, content=请问各位投稿成功的前辈，投稿必须要指定审稿人吗？对期刊审稿人并不了解，不知道填写谁该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ca6548418, createdName=ms5000000331764313, createdTime=Tue Aug 23 11:22:28 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214637, encodeId=a545121463efa, content=请问各位老师，杂志对综述友好吗？求解答～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037d5635603, createdName=ms4000001299708160, createdTime=Tue Apr 26 15:51:07 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208975, encodeId=817d12089e54a, content=请问对单位是医院会不会被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fa13814629, createdName=136dac36m33暂无昵称, createdTime=Wed Apr 06 14:24:44 CST 2022, time=2022-04-06, status=1, ipAttribution=)]

2022-04-26 ms4000001299708160

请问各位老师，杂志对综述友好吗？求解答～

42 0

[GetPortalCommentsPageByObjectIdResponse(id=2131287, encodeId=4228213128e14, content=偏重的研究方向：干细胞 经验分享：我想请问参考文献统一格式是endnote哪种格式，求告知，拜托。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Wed May 10 01:57:58 CST 2023, time=2023-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2107376, encodeId=3405210e376b5, content=请问这个期刊可以选择非OA吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Dec 25 00:15:21 CST 2022, time=2022-12-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=586208, encodeId=902d586208ca, content=请问该杂志允许有共同第一作者嘛？jianglin9112 2020-01-13 发表:: 可以用信用卡jianglin9112 2020-01-13 00:00:00 发表: 可以用信用卡, beContent=jianglin9112 2020-01-13 发表:: 可以用信用卡, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab905306038, createdName=148789b3m17(暂无昵称), createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=515864, encodeId=702d5158645d, content=atlaswang072650投了多久有消息的？为嘛我投了一篇当时就under view，到现在一个多月的还是under view，一点变化没有呢？太悲催了，另一篇投了个欧洲杂志，都快四个月了也还没消息，唉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201014/78bcaa77d72d4dc7ac25ab16c7d8ddec/d5dca58b57b849a79ee3182ba4376d18.jpg, createdBy=c15d1629831, createdName=bingliangai, createdTime=Sun Oct 11 18:00:00 CST 2015, time=2015-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137199, encodeId=e147213e199e6, content=投稿命中率:25.0 偏重的研究方向：干细胞 经验分享：这个直接拒稿了，投稿链接不好弄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://q.qlogo.cn/qqapp/1103841572/4F41B2F8F8D000E5AB77C572AE53CAE6/100, createdBy=9ed52073694, createdName=ms3590975155672967, createdTime=Wed May 17 21:09:15 CST 2023, time=2023-05-17, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2125934, encodeId=e639212593475, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：干细胞 经验分享：想问一下，大家修回去之后，大概多久有回复呀，大修返回去已经3个星期了，着急毕业呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:32:33 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2125936, encodeId=2e902125936ed, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：干细胞 经验分享：请问一下大修返回去之后，一般是多久有回复呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7aa8456461, createdName=ms2000000928550846, createdTime=Fri Apr 14 16:33:52 CST 2023, time=2023-04-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1240494, encodeId=115a1240494e0, content=请问各位投稿成功的前辈，投稿必须要指定审稿人吗？对期刊审稿人并不了解，不知道填写谁该怎么办呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07ca6548418, createdName=ms5000000331764313, createdTime=Tue Aug 23 11:22:28 CST 2022, time=2022-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214637, encodeId=a545121463efa, content=请问各位老师，杂志对综述友好吗？求解答～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=037d5635603, createdName=ms4000001299708160, createdTime=Tue Apr 26 15:51:07 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208975, encodeId=817d12089e54a, content=请问对单位是医院会不会被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fa13814629, createdName=136dac36m33暂无昵称, createdTime=Wed Apr 06 14:24:44 CST 2022, time=2022-04-06, status=1, ipAttribution=)]

2022-04-06 136dac36m33暂无昵称

请问对单位是医院会不会被拒

41 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务